Cel-Sci Corporation (CVM)
Cel-Sci Corporation Cash Investing: -0.0645M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
CVM Cash Investing Rankings
| Overall | 74th percentile | 1092 of 4324 |
| Sector | 64th percentile | 177 of 498 in Healthcare |
| Industry | 53rd percentile | 71 of 152 in Biotechnology |
CVM Cash Investing Range, Past 5 Years
| Minimum | -7.624M | Mar 2008 |
| Maximum | 5.265M | Jun 2008 |
| Average | -0.5189M |
About Cash Investing
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More
You may also be interested in these CVM related companies
CVM News
$CVM http://stks.co/3qe2 Looks ready to make a big move. Full video:
http://stks.co/3qe3
about 12 days ago by MarketScanners
about 12 days ago by MarketScanners
Small Biotech Companies Look to Benefit From Improvement of U.S. Patent System
May 11, 8:20AM Marketwire
May 11, 8:20AM Marketwire
$CVM It's like going to the gas station with a long line of cars and the attendant says " fill'er up at .50 before the train leaves"
about 18 days ago by BigKarma
about 18 days ago by BigKarma
What is that old song? ...dah dah dah "One of these charts, doesn't belong" Someone is waking $CVM http://chart.ly/odsvp6y
about 19 days ago by BigKarma
about 19 days ago by BigKarma
$CVM Classic cup and handle forming here. Confirmed on lower volume for handle as well.
about 21 days ago by BigKarma
about 21 days ago by BigKarma
RT @peterumble Short stocks: $EXEL $RGEN $PLX $POZN $CVM , markets hate uncertainty $SPY- SPY down 3.1% POZN up 0.8% since Wed. close. DD.
about 23 days ago by Glopolon
about 23 days ago by Glopolon
$CVM http://stks.co/3Zg2 See our complete break-out analysis at: http://stks.co/3Zg3
about 28 days ago by MarketScanners
about 28 days ago by MarketScanners
$CVM Get your bats out, Cel-Sci (AMEX:CVM) looks like a double form here
about 34 days ago by Accesswire
about 34 days ago by Accesswire
RT @adamfeuerstein $CVM and $BIEL as evidence I manipulate stocks. >It seems true....been watching you for 4 years now
about 46 days ago by earthdogpj
about 46 days ago by earthdogpj
$CVM could be an interesting long-term play with its Phase III clinical trial. They're taking an interesting approach to head/neck cancer.
about 61 days ago by jdkuepper
about 61 days ago by jdkuepper
@micheleciani : Thanks for $GALE...followed ur twits and got in at $1.41, now reaping the rewards. wanted your advise on $CVM?
about 67 days ago by hd147
about 67 days ago by hd147
$CVM filed latest Proxy Statement with the SEC (Form DEF 14A) http://stks.co/2yGW
about 69 days ago by MarketBrief
about 69 days ago by MarketBrief
CEL-SCI and Human Genome Sciences Poised to Benefit From Favorable Legislation
Mar 19, 8:20AM Marketwire
Mar 19, 8:20AM Marketwire
CEL-SCI and Threshold Pharmaceuticals on the Upswing as FDA Optimism Grows
Feb 23, 8:20AM Marketwire
Feb 23, 8:20AM Marketwire
CEL-SCI Corporation to Raise $5.76 Million in Registered Direct Offering
Jan 26, 9:15AM Business Wire
Jan 26, 9:15AM Business Wire
$INHX is done now $CVM and $IDIX will move look back in MAR11, I told you about INHX
about 132 days ago by JohnVan
about 132 days ago by JohnVan
$CVM Authorizes Expansion of Phase III Clinical Trial on Multikine to an Additional 4 European Countries
about 153 days ago by Benzinga
about 153 days ago by Benzinga
CEL-SCI (CVM) Expands Multikine Phase III to Spain, Czech Republic, Slovakia, Croatia
Dec 27, 8:46AM Street Insider
Dec 27, 8:46AM Street Insider
CEL- SCI Corporation Authorizes Expansion of Phase III Clinical Trial to an Additional 4 European Countries
Dec 27, 8:45AM Business Wire
Dec 27, 8:45AM Business Wire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CVM | 0.433 | -0.01 | -2.15% | 110.77M |
| CVLT | 47.97 | -2.04 | -4.08% | 2.120B |
| CVI | 26.56 | -0.61 | -2.25% | 2.299B |
| CVH | 30.63 | +0.65 | +2.17% | 4.325B |
| CVGW | 28.08 | +0.08 | +0.29% | 414.74M |
| CT | 3.35 | +0.05 | +1.52% | 74.40M |
| CSX | 21.37 | +0.02 | +0.09% | 22.21B |
| CSWC | 87.55 | -0.33 | -0.38% | 329.19M |
| CSV | 7.25 | +0.02 | +0.28% | 131.59M |
| CSUND | 1.20 | +0.03 | +2.56% |